Diabetes, Vol 42, Issue 7 1003-1009, Copyright © 1993 by American Diabetes Association
Inhibition of glucose-induced insulin secretion through inactivation of glucokinase by glyceraldehyde
T Murata, I Miwa, Y Toyoda and J Okuda
Department of Clinical Biochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
D-Glyceraldehyde irreversibly inhibited rat liver glucokinase in a
concentration-dependent manner. The inactivation of glucokinase by
glyceraldehyde was blocked by the presence of its substrates such as
glucose and mannose. Glucokinase was highly sensitive to glyceraldehyde
compared with some other glycolytic enzymes (from animal tissues) including
hexokinase, glucose-6-phosphate isomerase, 6-phosphofructokinase,
glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase. The amino
acid analysis of untreated and glyceraldehyde-treated glucokinase suggested
that glyceraldehyde-induced inactivation of glucokinase is caused by
glycation of Lys residues of the enzyme by the triose. Treatment of
pancreatic islets with 6 mM glyceraldehyde for 1 h at 37 degrees C caused
both inactivation of glucokinase and inhibition of glucose-induced insulin
secretion. Another glucose-phosphorylating enzyme (hexokinase) in
pancreatic islets, however, was little affected by glyceraldehyde. In
addition, glyceraldehyde did not affect the insulin secretory responses of
islets to nonglucose secretagogues such as glyceraldehyde and Leu. When
pancreatic islets were cultured with a lower concentration (1 mM) of
glyceraldehyde for a longer time (17 h) in the presence of 10 mM glucose to
mimic the in vivo conditions, both glucokinase activity and glucose-induced
insulin secretion were again decreased. This study demonstrates that
glucose-induced insulin secretion is impaired by glyceraldehyde through the
inactivation of glucokinase. The implication of this finding in the
pathophysiology of type II diabetes is discussed.